Curium in Finland
E-mail: orders.finland@curiumpharma.com
Web: https://www.curiumfinland.fi/
Addresses:
-
Office 1 Curium in Finland
Kivihaka (MAP), MAP Medical Technologies Oy, Kivihaantie 7 F, FI-00310 Helsinki
Phone: +358 14 334 5211
-
Office 2 Curium in Finland
Tikkakoski (MAP), MAP Medical Technologies Oy, Elementtitie 27, FI-41160 Tikkakoski
Phone: +358 14 334 5211
Other Curium's locations around the world
Clinical Trials sponsored by Curium
-
Curium US LLCAtivo, não recrutandoMetástase de Tumor Maligno da PróstataEstados Unidos, França, Espanha, Itália
-
Curium US LLCRecrutamentoCâncer de próstata | Adenocarcinoma de próstata | Recorrência Bioquímica de Neoplasia Maligna da PróstataEstados Unidos
-
Curium US LLCRecrutamentoCâncer de próstata | Adenocarcinoma de próstataEstados Unidos
-
Curium US LLCConcluídoMetástase de tumor maligno da próstata (distúrbio)Estados Unidos
-
Curium PET FranceAtivo, não recrutandoCâncer de Próstata RecorrenteFrança
-
Curium US LLCAprovado para comercializaçãoTumores Neuroendócrinos
-
Weill Medical College of Cornell UniversityCurium US LLCAinda não está recrutandoMeningiomaEstados Unidos
About Curium
At Curium, we have a singular focus – to develop, manufacture and supply world-class radiopharmaceutical products to customers around the globe. Drawing on years of proven experience, we aim to drive the nuclear medicine industry forward through excellence, reliability and unparalleled service. We develop, manufacture and distribute radiopharmaceutical products that meet industry-leading standards in quality, efficacy and innovation. Curium specialises in the production and supply of radioactive tracers used in nuclear medicine. By potentially enabling accurate early diagnosis and treatment of cancer, as well as heart, brain and bone diseases, our world-class products empower our customers with effective treatment, and proven patient outcomes.